Acridine derivatives inhibit lysozyme aggregation. 2008

Zuzana Gazova, and Andrea Bellova, and Zuzana Daxnerova, and Jan Imrich, and Pavol Kristian, and Jana Tomascikova, and Jaroslava Bagelova, and Diana Fedunova, and Marian Antalik
Department of Biophysics, Institute of Experimental Physics, Watsonova 47, 040 01, Kosice, Slovakia. gazova@saske.sk

We have screened a library of structurally distinct acridine derivatives (19 compounds) for their ability to inhibit lysozyme amyloid aggregation in vitro. Studied acridines were divided into three structurally different groups depending on the molecule planarity and type of the side chain-planar acridines, spiroacridines and tetrahydroacridines. Thioflavine T fluorescence assay and transmission electron microscopy were used for monitoring the inhibiting activity of acridines. We have found that both the structure of the acridine side chains and molecule planarity influence their antiamyloidogenic activity. The planar acridines inhibited lysozyme aggregation effectively. Spiroacridines and tetrahydroacridines had no significant effect on the prevention of lysozyme fibrillization, probably resulting from the presence of the heterocyclic 5-membered ring and non-planarity of molecule. Moreover, in the presence of some tetrahydroacridines the enhanced extent of aggregation was detected. We identified the most active acridine derivates from studied compound library characterized by low micromolar IC50 values, which indicate their possible application for therapeutic purpose.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009113 Muramidase A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17. Lysozyme,Leftose,N-Acetylmuramide Glycanhydrolase,Glycanhydrolase, N-Acetylmuramide,N Acetylmuramide Glycanhydrolase
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000166 Acridines Compounds that include the structure of acridine. Acridine
D000682 Amyloid A fibrous protein complex that consists of proteins folded into a specific cross beta-pleated sheet structure. This fibrillar structure has been found as an alternative folding pattern for a variety of functional proteins. Deposits of amyloid in the form of AMYLOID PLAQUES are associated with a variety of degenerative diseases. The amyloid structure has also been found in a number of functional proteins that are unrelated to disease. Amyloid Fibril,Amyloid Fibrils,Amyloid Substance,Fibril, Amyloid,Fibrils, Amyloid,Substance, Amyloid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

Zuzana Gazova, and Andrea Bellova, and Zuzana Daxnerova, and Jan Imrich, and Pavol Kristian, and Jana Tomascikova, and Jaroslava Bagelova, and Diana Fedunova, and Marian Antalik
April 2011, Biochimica et biophysica acta,
Zuzana Gazova, and Andrea Bellova, and Zuzana Daxnerova, and Jan Imrich, and Pavol Kristian, and Jana Tomascikova, and Jaroslava Bagelova, and Diana Fedunova, and Marian Antalik
June 2022, RSC advances,
Zuzana Gazova, and Andrea Bellova, and Zuzana Daxnerova, and Jan Imrich, and Pavol Kristian, and Jana Tomascikova, and Jaroslava Bagelova, and Diana Fedunova, and Marian Antalik
April 2013, Biomacromolecules,
Zuzana Gazova, and Andrea Bellova, and Zuzana Daxnerova, and Jan Imrich, and Pavol Kristian, and Jana Tomascikova, and Jaroslava Bagelova, and Diana Fedunova, and Marian Antalik
June 2022, Molecules (Basel, Switzerland),
Zuzana Gazova, and Andrea Bellova, and Zuzana Daxnerova, and Jan Imrich, and Pavol Kristian, and Jana Tomascikova, and Jaroslava Bagelova, and Diana Fedunova, and Marian Antalik
June 2022, RSC advances,
Zuzana Gazova, and Andrea Bellova, and Zuzana Daxnerova, and Jan Imrich, and Pavol Kristian, and Jana Tomascikova, and Jaroslava Bagelova, and Diana Fedunova, and Marian Antalik
April 1972, Die Pharmazie,
Zuzana Gazova, and Andrea Bellova, and Zuzana Daxnerova, and Jan Imrich, and Pavol Kristian, and Jana Tomascikova, and Jaroslava Bagelova, and Diana Fedunova, and Marian Antalik
January 2014, Biological & pharmaceutical bulletin,
Zuzana Gazova, and Andrea Bellova, and Zuzana Daxnerova, and Jan Imrich, and Pavol Kristian, and Jana Tomascikova, and Jaroslava Bagelova, and Diana Fedunova, and Marian Antalik
November 1971, Clinical chemistry,
Zuzana Gazova, and Andrea Bellova, and Zuzana Daxnerova, and Jan Imrich, and Pavol Kristian, and Jana Tomascikova, and Jaroslava Bagelova, and Diana Fedunova, and Marian Antalik
January 2023, Frontiers in pharmacology,
Zuzana Gazova, and Andrea Bellova, and Zuzana Daxnerova, and Jan Imrich, and Pavol Kristian, and Jana Tomascikova, and Jaroslava Bagelova, and Diana Fedunova, and Marian Antalik
October 1951, Hospital (Rio de Janeiro, Brazil),
Copied contents to your clipboard!